Global Non-ionic Iodine Contrast Media Market Research Report 2021

1 Non-ionic Iodine Contrast Media Market Overview

• 1.1 Product Overview and Scope of Non-ionic Iodine Contrast Media
• 1.2 Non-ionic Iodine Contrast Media Segment by Type
  • 1.2.1 Global Non-ionic Iodine Contrast Media Sales Growth Rate Comparison by Type (2021-2027)
  • 1.2.2 Iohexol
  • 1.2.3 Iodixanol
  • 1.2.4 Iopamidol
  • 1.2.5 Ioversol
  • 1.2.6 Others
• 1.3 Non-ionic Iodine Contrast Media Segment by Application
  • 1.3.1 Global Non-ionic Iodine Contrast Media Sales Comparison by Application: (2021-2027)
  • 1.3.2 Hospitals
  • 1.3.3 Clinics
• 1.4 Global Non-ionic Iodine Contrast Media Market Size Estimates and Forecasts
  • 1.4.1 Global Non-ionic Iodine Contrast Media Revenue 2016-2027
  • 1.4.2 Global Non-ionic Iodine Contrast Media Sales 2016-2027
  • 1.4.3 Non-ionic Iodine Contrast Media Market Size by Region: 2016 Versus 2021 Versus 2027

2 Non-ionic Iodine Contrast Media Market Competition by Manufacturers

• 2.1 Global Non-ionic Iodine Contrast Media Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global Non-ionic Iodine Contrast Media Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global Non-ionic Iodine Contrast Media Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers Non-ionic Iodine Contrast Media Manufacturing Sites, Area Served, Product Type
• 2.5 Non-ionic Iodine Contrast Media Market Competitive Situation and Trends
  • 2.5.1 Non-ionic Iodine Contrast Media Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Non-ionic Iodine Contrast Media Players Market Share by Revenue
  • 2.5.3 Global Non-ionic Iodine Contrast Media Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Non-ionic Iodine Contrast Media Retrospective Market Scenario by Region

• 3.1 Global Non-ionic Iodine Contrast Media Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.2 Global Non-ionic Iodine Contrast Media Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.3 North America Non-ionic Iodine Contrast Media Market Facts & Figures by Country
  • 3.3.1 North America Non-ionic Iodine Contrast Media Sales by Country
  • 3.3.2 North America Non-ionic Iodine Contrast Media Revenue by Country
  • 3.3.3 United States
  • 3.3.4 Canada
• 3.4 Europe Non-ionic Iodine Contrast Media Market Facts & Figures by Country
  • 3.4.1 Europe Non-ionic Iodine Contrast Media Sales by Country
  • 3.4.2 Europe Non-ionic Iodine Contrast Media Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Non-ionic Iodine Contrast Media Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Non-ionic Iodine Contrast Media Sales by Region
  • 3.5.2 Asia Pacific Non-ionic Iodine Contrast Media Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 China Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
• 3.6 Latin America Non-ionic Iodine Contrast Media Market Facts & Figures by Country
  • 3.6.1 Latin America Non-ionic Iodine Contrast Media Sales by Country
  • 3.6.2 Latin America Non-ionic Iodine Contrast Media Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
• 3.7 Middle East and Africa Non-ionic Iodine Contrast Media Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Non-ionic Iodine Contrast Media Sales by Country
  • 3.7.2 Middle East and Africa Non-ionic Iodine Contrast Media Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 UAE

4 Global Non-ionic Iodine Contrast Media Historic Market Analysis by Type

• 4.1 Global Non-ionic Iodine Contrast Media Sales Market Share by Type (2016-2021)
• 4.2 Global Non-ionic Iodine Contrast Media Revenue Market Share by Type (2016-2021)
• 4.3 Global Non-ionic Iodine Contrast Media Price by Type (2016-2021)

5 Global Non-ionic Iodine Contrast Media Historic Market Analysis by Application

• 5.1 Global Non-ionic Iodine Contrast Media Sales Market Share by Application (2016-2021)
• 5.2 Global Non-ionic Iodine Contrast Media Revenue Market Share by Application (2016-2021)
• 5.3 Global Non-ionic Iodine Contrast Media Price by Application (2016-2021)

6 Key Companies Profiled

• 6.1 GE Healthcare
  • 6.1.1 GE Healthcare Corporation Information
  • 6.1.2 GE Healthcare Description and Business Overview
  • 6.1.3 GE Healthcare Non-ionic Iodine Contrast Media Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 GE Healthcare Non-ionic Iodine Contrast Media Product Portfolio
  • 6.1.5 GE Healthcare Recent Developments/Updates
• 6.2 Bayer
  • 6.2.1 Bayer Corporation Information
  • 6.2.2 Bayer Description and Business Overview
  • 6.2.3 Bayer Non-ionic Iodine Contrast Media Sales, Revenue and Gross Margin (2016-2021)
  • 6.2.4 Bayer Non-ionic Iodine Contrast Media Product Portfolio
  • 6.2.5 Bayer Recent Developments/Updates
• 6.3 Bracco Imaging
  • 6.3.1 Bracco Imaging Corporation Information
  • 6.3.2 Bracco Imaging Description and Business Overview
  • 6.3.3 Bracco Imaging Non-ionic Iodine Contrast Media Sales, Revenue and Gross Margin (2016-2021)
  • 6.3.4 Bracco Imaging Non-ionic Iodine Contrast Media Product Portfolio
  • 6.3.5 Bracco Imaging Recent Developments/Updates
• 6.4 Guerbet Group
  • 6.4.1 Guerbet Group Corporation Information
  • 6.4.2 Guerbet Group Description and Business Overview
  • 6.4.3 Guerbet Group Non-ionic Iodine Contrast Media Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Guerbet Group Non-ionic Iodine Contrast Media Product Portfolio
  • 6.4.5 Guerbet Group Recent Developments/Updates
• 6.5 Hengrui Medicine
  • 6.5.1 Hengrui Medicine Corporation Information
  • 6.5.2 Hengrui Medicine Description and Business Overview
  • 6.5.3 Hengrui Medicine Non-ionic Iodine Contrast Media Sales, Revenue and Gross Margin (2016-2021)
  • 6.5.4 Hengrui Medicine Non-ionic Iodine Contrast Media Product Portfolio
  • 6.5.5 Hengrui Medicine Recent Developments/Updates
• 6.6 Lantheus
  • 6.6.1 Lantheus Corporation Information
  • 6.6.2 Lantheus Description and Business Overview
  • 6.6.3 Lantheus Non-ionic Iodine Contrast Media Sales, Revenue and Gross Margin (2016-2021)
  • 6.6.4 Lantheus Non-ionic Iodine Contrast Media Product Portfolio
  • 6.6.5 Lantheus Recent Developments/Updates
• 6.7 YRPG
  • 6.6.1 YRPG Corporation Information
  • 6.6.2 YRPG Description and Business Overview
  • 6.6.3 YRPG Non-ionic Iodine Contrast Media Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 YRPG Non-ionic Iodine Contrast Media Product Portfolio
  • 6.7.5 YRPG Recent Developments/Updates
• 6.8 BeiLu Pharma
  • 6.8.1 BeiLu Pharma Corporation Information
  • 6.8.2 BeiLu Pharma Description and Business Overview
  • 6.8.3 BeiLu Pharma Non-ionic Iodine Contrast Media Sales, Revenue and Gross Margin (2016-2021)
  • 6.8.4 BeiLu Pharma Non-ionic Iodine Contrast Media Product Portfolio
  • 6.8.5 BeiLu Pharma Recent Developments/Updates
• 6.9 Sanochemia
  • 6.9.1 Sanochemia Corporation Information
  • 6.9.2 Sanochemia Description and Business Overview
  • 6.9.3 Sanochemia Non-ionic Iodine Contrast Media Sales, Revenue and Gross Margin (2016-2021)
  • 6.9.4 Sanochemia Non-ionic Iodine Contrast Media Product Portfolio
  • 6.9.5 Sanochemia Recent Developments/Updates
• 6.10 Tyco Healthcare
  • 6.10.1 Tyco Healthcare Corporation Information
  • 6.10.2 Tyco Healthcare Description and Business Overview
  • 6.10.3 Tyco Healthcare Non-ionic Iodine Contrast Media Sales, Revenue and Gross Margin (2016-2021)
  • 6.10.4 Tyco Healthcare Non-ionic Iodine Contrast Media Product Portfolio
  • 6.10.5 Tyco Healthcare Recent Developments/Updates
• 6.11 Imax
  • 6.11.1 Imax Corporation Information
  • 6.11.2 Imax Non-ionic Iodine Contrast Media Description and Business Overview
  • 6.11.3 Imax Non-ionic Iodine Contrast Media Sales, Revenue and Gross Margin (2016-2021)
  • 6.11.4 Imax Non-ionic Iodine Contrast Media Product Portfolio
  • 6.11.5 Imax Recent Developments/Updates
• 6.12 Grupo Juste
  • 6.12.1 Grupo Juste Corporation Information
  • 6.12.2 Grupo Juste Non-ionic Iodine Contrast Media Description and Business Overview
  • 6.12.3 Grupo Juste Non-ionic Iodine Contrast Media Sales, Revenue and Gross Margin (2016-2021)
  • 6.12.4 Grupo Juste Non-ionic Iodine Contrast Media Product Portfolio
  • 6.12.5 Grupo Juste Recent Developments/Updates
• 6.13 Daiichi Sankyo
  • 6.13.1 Daiichi Sankyo Corporation Information
  • 6.13.2 Daiichi Sankyo Non-ionic Iodine Contrast Media Description and Business Overview
  • 6.13.3 Daiichi Sankyo Non-ionic Iodine Contrast Media Sales, Revenue and Gross Margin (2016-2021)
  • 6.13.4 Daiichi Sankyo Non-ionic Iodine Contrast Media Product Portfolio
  • 6.13.5 Daiichi Sankyo Recent Developments/Updates
• 6.14 Takeda
  • 6.14.1 Takeda Corporation Information
  • 6.14.2 Takeda Non-ionic Iodine Contrast Media Description and Business Overview
  • 6.14.3 Takeda Non-ionic Iodine Contrast Media Sales, Revenue and Gross Margin (2016-2021)
  • 6.14.4 Takeda Non-ionic Iodine Contrast Media Product Portfolio
  • 6.14.5 Takeda Recent Developments/Updates
• 6.15 Fuji Pharma
  • 6.15.1 Fuji Pharma Corporation Information
  • 6.15.2 Fuji Pharma Non-ionic Iodine Contrast Media Description and Business Overview
  • 6.15.3 Fuji Pharma Non-ionic Iodine Contrast Media Sales, Revenue and Gross Margin (2016-2021)
  • 6.15.4 Fuji Pharma Non-ionic Iodine Contrast Media Product Portfolio
  • 6.15.5 Fuji Pharma Recent Developments/Updates
• 6.16 Towaseiyaku
  • 6.16.1 Towaseiyaku Corporation Information
  • 6.16.2 Towaseiyaku Non-ionic Iodine Contrast Media Description and Business Overview
  • 6.16.3 Towaseiyaku Non-ionic Iodine Contrast Media Sales, Revenue and Gross Margin (2016-2021)
  • 6.16.4 Towaseiyaku Non-ionic Iodine Contrast Media Product Portfolio
  • 6.16.5 Towaseiyaku Recent Developments/Updates
• 6.17 Hikari Pharmaceutical
  • 6.17.1 Hikari Pharmaceutical Corporation Information
  • 6.17.2 Hikari Pharmaceutical Non-ionic Iodine Contrast Media Description and Business Overview
  • 6.17.3 Hikari Pharmaceutical Non-ionic Iodine Contrast Media Sales, Revenue and Gross Margin (2016-2021)
  • 6.17.4 Hikari Pharmaceutical Non-ionic Iodine Contrast Media Product Portfolio
  • 6.17.5 Hikari Pharmaceutical Recent Developments/Updates
• 6.18 Consentis Diagnostics GmbH
  • 6.18.1 Consentis Diagnostics GmbH Corporation Information
  • 6.18.2 Consentis Diagnostics GmbH Non-ionic Iodine Contrast Media Description and Business Overview
  • 6.18.3 Consentis Diagnostics GmbH Non-ionic Iodine Contrast Media Sales, Revenue and Gross Margin (2016-2021)
  • 6.18.4 Consentis Diagnostics GmbH Non-ionic Iodine Contrast Media Product Portfolio
  • 6.18.5 Consentis Diagnostics GmbH Recent Developments/Updates
• 6.19 T2Pharma
  • 6.19.1 T2Pharma Corporation Information
  • 6.19.2 T2Pharma Non-ionic Iodine Contrast Media Description and Business Overview
  • 6.19.3 T2Pharma Non-ionic Iodine Contrast Media Sales, Revenue and Gross Margin (2016-2021)
  • 6.19.4 T2Pharma Non-ionic Iodine Contrast Media Product Portfolio
  • 6.19.5 T2Pharma Recent Developments/Updates

7 Non-ionic Iodine Contrast Media Manufacturing Cost Analysis

• 7.1 Non-ionic Iodine Contrast Media Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Non-ionic Iodine Contrast Media
• 7.4 Non-ionic Iodine Contrast Media Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Non-ionic Iodine Contrast Media Distributors List
• 8.3 Non-ionic Iodine Contrast Media Customers

9 Non-ionic Iodine Contrast Media Market Dynamics

• 9.1 Non-ionic Iodine Contrast Media Industry Trends
• 9.2 Non-ionic Iodine Contrast Media Growth Drivers
• 9.3 Non-ionic Iodine Contrast Media Market Challenges
• 9.4 Non-ionic Iodine Contrast Media Market Restraints

10 Global Market Forecast

• 10.1 Non-ionic Iodine Contrast Media Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Non-ionic Iodine Contrast Media by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of Non-ionic Iodine Contrast Media by Type (2022-2027)
• 10.2 Non-ionic Iodine Contrast Media Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Non-ionic Iodine Contrast Media by Application (2022-2027)
  • 10.2.2 Global Forecasted Revenue of Non-ionic Iodine Contrast Media by Application (2022-2027)
• 10.3 Non-ionic Iodine Contrast Media Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Non-ionic Iodine Contrast Media by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of Non-ionic Iodine Contrast Media by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List